Cutting-Edge Cancer Care
January 31, 2025
We are thrilled to announced that ECHO has enrolled the first patient in the world into a new clinical trial. The trial is for patients with metastatic Non-Small Cell Lung Cancer (NSCLC) who have progressed while receiving maintenance immunotherapy. The trial will compare […]